STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1773 by analyst upside · 2026-06-27
ENSG
The Ensign Group, Inc.
Healthcare · Market Cap $10B · P/E 26.5x
ANALYST PRICE TARGET
+35.2%
implied upside to consensus target
Current Price $163.05
Consensus Target $220.4
Bull Target $230.0
Bear Target $210.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
3
Hold
1
Sell
0
52-Week Low $134.79
52-Week High $218.0
YTD Return -6.2%
FUNDAMENTALS
Market Cap $10B
P/E Ratio (TTM) 26.5x
Forward P/E 19.6x
EPS (TTM) $6.15
PEG Ratio 1.45
Dividend Yield 16.00%
Revenue (TTM) $5.3B
Profit Margin 6.9%
52-WEEK RANGE
52-Week Low $134.79
52-Week High $218.0
Current Price $163.05
Bear Target $210.0
Bull Target $230.0
● Now $163.05 ● Target $220.4
TRADING DATA
Avg Volume 646K
YTD Return -6.2%
Analyst Count 5
Consensus Buy
Upside to Target +35.2%
Last Updated 2026-06-27

ANALYST SUMMARY

The Ensign Group, Inc. (ENSG) is currently trading at $163.05 with a Wall Street consensus price target of $220.4, implying potential upside of 35.2% over the next 12 months. 5 analysts currently cover ENSG, with a consensus rating of Buy - 80% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $230.0, while the most cautious has a target of $210.0.

ENSG operates in the Healthcare sector with a market capitalisation of $10B. The stock is down 6.2% year-to-date and is currently trading near the lower end of its 52-week range of $134.79 – $218.0.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ENSG, with each firm's 90-day track record across all stocks we track. See full firm rankings →

RBC Capital — Reiterated
Outperform → Outperform 2026-02-09 Building track record
Truist Securities — Reiterated
Hold → Hold 2026-02-06 Building track record
RBC Capital — Reiterated
Outperform → Outperform 2025-11-14 Building track record
Truist Securities — Reiterated
Hold → Hold 2025-11-10 Building track record
UBS — Reiterated
Buy → Buy 2025-11-05 33% win rate (6 calls)
Stephens & Co. — Reiterated
Overweight → Overweight 2025-11-05 Building track record
UBS — Reiterated
Buy → Buy 2025-09-02 33% win rate (6 calls)
UBS — Reiterated
Buy → Buy 2025-08-14 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
64
out of 100
Coverage depth
14/30
Consensus clarity
28/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →